1. Improved diagnostic performance of susceptibility-weighted imaging with compressed sensing-sensitivity encoding and neuromelanin-sensitive MRI for Parkinson's disease and atypical Parkinsonism.
- Author
-
Lee, D.H., Heo, H., Suh, C.H., Shim, W.H., Kim, E., Jo, S., Chung, S.J., Lee, C.S., Kim, H.S., and Kim, S.J.
- Subjects
- *
PARKINSON'S disease , *PARKINSONIAN disorders , *MAGNETIC resonance imaging , *MELANINS , *ENCODING - Abstract
To verify the diagnostic performance of the loss of nigrosome-1 on susceptibility-weighted imaging (SWI) with compressed sensing-sensitivity encoding (CS-SENSE) and neuromelanin on neuromelanin-sensitive (NM) magnetic resonance imaging (MRI) for the diagnosis of Parkinson's disease (PD) and atypical Parkinsonism. A total of 195 patients who underwent MRI between October 2019 and February 2020, including SWI, with or without CS-SENSE, and NM-MRI, were reviewed retrospectively. Two neuroradiologists assessed the loss of nigrosome-1 on SWI and neuromelanin on the NM-MRI. The result of N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane positron-emission tomography (PET) was set as the reference standard. When CS-SENSE was applied for nigrosome-1 imaging on SWI, the non-diagnostic scan rate was lowered significantly from 19.3% (17/88) to 5.6% (6/107; p =0.004). Diagnosis of PD and atypical Parkinsonism based on the loss of nigrosome-1 on SWI and based on NM-MRI showed good diagnostic value (area under the curve [AUC] 0.821, 95% confidence interval [CI] = 0.755–0.875: AUC 0.832, 95% CI = 0.771–0.882, respectively) with a substantial inter-reader agreement (κ = 0.791 and 0.681, respectively). Combined SWI and neuromelanin had a similar discriminatory ability (AUC 0.830, 95% CI = 0.770–0.880). Similarly, the diagnosis of PD was excellent. CS-SENSE may add value to the diagnostic capability of nigrosome-1 on SWI to reduce the nondiagnostic scan rates. Furthermore, loss of nigrosome-1 on SWI or volume loss of neuromelanin on NM-MRI may be helpful for diagnosing PD. • CS-SENSE on SWI for the nigrosome-1 reduced nondiagnostic scan and acquisition time. • CS-SENSE for the nigrosome-1 improved diagnostic performance for PD and Parkinsonism. • Neuromelanin on NM-MRI indicated a comparable diagnostic ability to nigrosome-1 on SWI. • NM-MRI had a lower nondiagnostic scan rate than SWI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF